anonymous
Guest
anonymous
Guest
the drug is 38,892 for 2 1/2 weeks with very little clinical data and some half ass attempt by mnk to fund trials for window dressing. Collapse will follow Q2 next year.
Well if we have no data CADs can use why have them. Get rid of half of thm and have the ones we have return the last 5 years of salary. They have done jack shittt